4
Changes in Ownership
ANAPTYSBIO, INC Filed Acc 0001209191-21-070986
President, CEO sold 36,645 shares at an average $35.57 ($1,303,559)
- President, CEO acquired 36,645 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Suria Hamza President, CEO | 2021-12-20 | Option exercise | +36,645 | $1.12 | $41,042 | 105,245 | D: show line 1 in the form |
| Suria Hamza President, CEO | 2021-12-20 | Sale | −11,915 | $34.89 | $415,756 | 93,330 | D: show line 2 in the form |
| Suria Hamza President, CEO | 2021-12-20 | Sale | −19,208 | $35.75 | $686,776 | 74,122 | D: show line 3 in the form |
| Suria Hamza President, CEO | 2021-12-20 | Sale | −5,522 | $36.40 | $201,026 | 68,600 | D: show line 4 in the form |
| Open-market sales · 36,645 sh · avg $35.57 · $1,303,559 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Suria Hamza President, CEO | 2021-12-20 | Option exercise · Employee Stock Option (Right to Buy) | −36,645 | 0 | D: show line 5 in the form |
Loading xslF345X03/doc4.xml…